Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

A Review Of The French Maritime Pine Bark Extract (Pycnogenol), A Herbal Medication With A Diverse Clinical Pharmacology.

P. Rohdewald
Published 2002 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
OBJECTIVES An increasing body of evidence indicates that Pycnogenol (PYC), a standardized extract of French maritime pine bark, has favorable pharmacological properties. This is a review of studies with both PYC and components of the preparation, that have helped to elucidate target sites and possible mechanisms for activity in men. METHODS Studies appearing in peer reviewed literature, as well as results presented at international meetings not yet available as published papers, are included in this review. Additional data from published sources in German and French languages that are not widely available are also included. RESULTS Chemical identification studies showed that PYC is primarily composed of procyanidins and phenolic acids. Procyanidins are biopolymers of catechin and epicatechin subunits which are recognized as important constituents in human nutrition. PYC contains a wide variety of procyanidins that range from the monomeric catechin and taxifolin to oligomers with 7 or more flavonoid subunits. The phenolic acids are derivatives of benzoic and cinnamic acids. The ferulic acid and taxifolin components are rapidly absorbed and excreted as glucuronides or sulphates in men, whereas procyanidins are absorbed slowly and metabolized to valerolactones which are excreted as glucuronides. PYC has low acute and chronic toxicity with mild unwanted effects occurring in a small percentage of patients following oral administration. Clinical studies indicate that PYC is effective in the treatment of chronic venous insufficiency and retinal micro-hemorrhages. PYC protects against oxidative stress in several cell systems by doubling the intracellular synthesis of anti-oxidative enzymes and by acting as a potent scavenger of free radicals. Other anti-oxidant effects involve a role in the regeneration and protection of vitamin C and E. Anti-inflammatory activity has been demonstrated in vitro and in vivo in animals. Protection against UV-radiation-induced erythema was found in a clinical study following oral intake of PYC. In asthma patients symptom scores and circulating leukotrienes are reduced and lung function is improved. Immunomodulation has been observed in both animal models as well as in patients with Lupus erythematosus. PYC antagonizes the vasoconstriction caused by epinephrine and norepinephrine by increasing the activity of endothelial nitric oxide synthase. Dilation of the small blood vessels has been observed in patients with cardiovascular disease, whereas in smokers, PYC prevents smoking-induced platelet aggregation and reduces the concentration of thromboxane. The ability to inhibit angiotensin-converting enzyme is associated with a mild antihypertensive effect. PYC relieves premenstrual symptoms, including abdominal pain and this action may be associated with the spasmolytic action of some phenolic acids. An improvement in cognitive function has been observed in controlled animal experiments and these findings support anecdotal reports of improvement in ADHD patients taking PYC supplements. CONCLUSIONS There is much evidence showing that PYC has beneficial effects on physiological functions. Results from ongoing clinical research are required to confirm and extend previous observations.

This paper is referenced by
Treatment of chronic venous disease with flavonoids: recommendations for treatment and further studies
E. Rabe (2013)
The Shelf Life and Meat Quality of Broilers Fed Pine Bark Extract (Pitamin)
Byung-sung Park (2009)
The Effects of Pycnogenol® as Add‐on Drug to Metformin Therapy in Diabetic Rats
S. Jankyova (2016)
Prevention of Edema in Long Flights with Pycnogenol®
M. Cesarone (2005)
Dietary supplementation with procyanidin-rich Pinus pinaster extract is associated with attenuated Ehrlich tumor development in mice.
I. M. David (2019)
Variations in Echogenicity in Carotid and Femoral Atherosclerotic Plaques with Pycnogenol + Centella Asiatica Supplementation
G. Belcaro (2017)
H. Hassan (2007)
Zinopin® – the rationale for its use as a food supplement in traveller's thrombosis and motion sickness
J. Scurr (2004)
Effects of Flavangenol on Autonomic Nerve Activities and Dietary Body Weight Gain in Rats
M. Tanida (2009)
Another potential drug in the treatment of diabetic retinopathy
Kevin Shotliff Consultant Physician (2004)
Anti‐wrinkling effects of the mixture of vitamin C, vitamin E, pycnogenol and evening primrose oil, and molecular mechanisms on hairless mouse skin caused by chronic ultraviolet B irradiation
Ho-Song Cho (2007)
Inhibitory Effects of Anti‐Oxidants on Apoptosis of a Human Polyclonal T‐Cell Line, MT‐2, Induced by an Asbestos, Chrysotile‐A
F. Hyodoh (2005)
Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (pycnogenol).
T. Grimm (2004)
Hydroxycinnamic Acids: Natural Sources, Biosynthesis, Possible Biological Activities, and Roles in Islamic Medicine
H. El-Seedi (2017)
Review on Sustained Relief of Osteoarthritis Symptoms with a Proprietary Extract from Pine Bark, Pycnogenol
R. Jörg (2017)
Investigation on chemical composition, anticholinesterase and antioxidant activities of extracts and essential oils of Turkish Pinus species and pycnogenol
Osman Üstün (2012)
A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract.
A. Maimoona (2011)
Chemical composition, antioxidative activity and cell viability effects of a Siberian pine (Pinus sibirica Du Tour) extract
T. A. Lantto (2009)
Review: Influence of combinations of Pycnogenol® and L-arginine aspartate on men’s virility and fertility
A randomized controlled trial investigating the effect of Pycnogenol and Bacopa CDRI08 herbal medicines on cognitive, cardiovascular, and biochemical functioning in cognitively healthy elderly people: the Australian Research Council Longevity Intervention
C. Stough (2020)
Omega-3 fatty acid status in attention-deficit/hyperactivity disorder.
Caryl J Antalis (2006)
Diabetic Ulcers: Microcirculatory Improvement and Faster Healing With Pycnogenol
G. Belcaro (2006)
Induction de la vasodilatation d'un vaisseau sanguin périphérique
C. Kwik-Uribe (2006)
French maritime pine bark extract Pycnogenol dose-dependently lowers glucose in type 2 diabetic patients.
X. Liu (2004)
Single and multiple dose pharmacokinetics of maritime pine bark extract (Pycnogenol) after oral administration to healthy volunteers
T. Grimm (2006)
A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance – Part 28
K. Currell (2011)
Nutritional and dietary influences on attention deficit hyperactivity disorder.
N. Sinn (2008)
French maritime pine bark extract inhibits viral replication and prevents development of viral myocarditis.
A. Matsumori (2007)
Effects of the Mixture of Vitamin C, Vitamin E, Pycnogenol and Evening Primrose Oil on the UV-Induced Pigmentation and Wrinkle Reductions in Human Skin
Min-Youl Chang (2009)
The truth about over-the-counter topical anti-aging products: a comprehensive review.
Catherine K. Huang (2007)
The stabilizing effect of an oligomeric proanthocyanidin on red blood cell membrane structure of poorly controlled Type II diabetes
J. Visser (2017)
9. Cosmetics and cosmeceuticals
M. Kerscher (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar